Department of Psychiatry, Henry Ford Health System, 1 Ford Place, Detroit, MI 48202.
Department of Psychiatry, Henry Ford Hospital/Wayne State University, Detroit, Michigan, USA.
Prim Care Companion CNS Disord. 2020 Dec 10;22(6):20m02625. doi: 10.4088/PCC.20m02625.
Nonadherence to pharmacotherapy for psychiatric conditions is associated with poor outcomes, including increased risk of relapse, increased health care costs, and reduced quality of life. The objective of this study was to investigate the strength of association between socioeconomic factors, race/ethnicity, and patient perceptions with medication adherence in individuals with depression.
Baseline surveys were sent out in 2012 to 4,216 adult patients within a large health system who presented with a clinical diagnosis of major depressive disorder (ICD-9), recorded at least twice in the electronic medical record in the year 2011. A total of 1,573 patients responded to the baseline survey. Of those, 1,209 patients who completed the survey and had used antidepressants in the last 12 months were recruited for the study. Perception of medication risk was assessed using the Beliefs About Medicines Questionnaire, and adherence to medications was assessed using the Morisky Medication Adherence Scale. Logistic regression was used to investigate the relationship between perception of medicine risk and treatment adherence.
For non-Hispanic white individuals, medication adherence was higher among those who were least concerned about the risk of medications (64%; 95% CI, 58-70) compared to those who were most concerned (34%; 95% CI, 26-43). In the logistic regression model, less concern about medications and their side effects was associated with higher medication adherence (odds ratio = 2.6; 95% CI, 1.77-3.84; P < .0001). This association remained significant after adjustment for age, race, education level, and extramedical use of other medications or substances. Moreover, patients with older age and lower education level as well as those who were non-Hispanic white and had no extramedical use of other medications/substances were more likely to be adherent to medications.
This study contributes quantitative data on factors that impact treatment adherence. Identifying patients at increased risk of nonadherence, having discussions with patients early in the treatment process to understand their concerns regarding treatment options, being sensitive to cultural beliefs, and patiently proceeding with the decision-making process could help ensure better outcomes.
精神疾病药物治疗的不依从与不良结局相关,包括复发风险增加、医疗保健费用增加和生活质量降低。本研究的目的是调查社会经济因素、种族/民族和患者对药物治疗的看法与抑郁患者药物依从性之间的关联强度。
2012 年,向大型医疗系统内 4216 名出现临床诊断为重度抑郁症(ICD-9)的成年患者发送了基线调查,这些患者在 2011 年的电子病历中至少记录了两次。共有 1573 名患者对基线调查做出了回应。其中,有 1209 名完成了调查且在过去 12 个月内使用过抗抑郁药的患者被纳入了本研究。使用信念量表评估对药物的风险感知,使用 Morisky 药物依从量表评估药物依从性。采用 logistic 回归分析评估药物风险感知与治疗依从性之间的关系。
对于非西班牙裔白人个体,对药物风险最不关注的患者(64%;95%CI,58-70)药物依从性高于最关注的患者(34%;95%CI,26-43)。在 logistic 回归模型中,对药物及其副作用的担忧程度较低与更高的药物依从性相关(比值比=2.6;95%CI,1.77-3.84;P<.0001)。在调整年龄、种族、教育水平以及非医疗使用其他药物或物质后,这种关联仍然显著。此外,年龄较大、教育程度较低、非西班牙裔白人和非医疗使用其他药物/物质的患者更有可能坚持药物治疗。
本研究提供了影响治疗依从性的因素的定量数据。识别出依从性较差的患者,在治疗早期与患者进行讨论,了解他们对治疗方案的担忧,对文化信仰保持敏感,耐心地进行决策过程,这些都有助于确保更好的治疗结局。